Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT, and what generic and branded alternatives to SAGENT drugs are available?
SAGENT has eighty-eight approved drugs.
There is one tentative approval on SAGENT drugs.
Drugs and US Patents for Sagent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201851-001 | Nov 6, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 091458-001 | Jul 28, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent | FAMOTIDINE | famotidine | INJECTABLE;INJECTION | 075651-001 | Apr 16, 2001 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 091048-001 | Jan 4, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.